lumacaftor
ItalyDrugs containing this active substance
-
It is used for the long-term treatment of cystic fibrosis in patients (aged 1 year and older) who have a specific genetic mutation called F508del.
Form: tablets, film-coated
Active substance Dosage ivacaftor - lumacaftor - ATC: R07AX30
Manufacturer: VERTEX PHARMACEUTICALS (IRELAND) LIMITED